Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. by Joseph Rabin (7399436)

Subjects:

Hypothesis that explains and predicts expansion of ages of KD due to decreased IgG levels. by Hiromi Yamaguchi (2396248)

Subjects:

rhMG53 decreases membrane damage <i>in vitro</i>. by Brian J. Paleo (8694246)

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

Quantitative decrease of apolipoprotein-A1 by cohort. by Thierry Poynard (38084)

Post-losartan treatment prevented SARS-CoV-2 spike protein-induced decreased cognitive impairment but not pre-losartan treatment. by Mackenzi Meier (19251139)

Methyl Gallate (MG) treatment decreases hepatocellular carcinoma (HCC) cell survival. by Chien-Yu Huang (802982)

Decrease of apolipoprotein-A1 by gender and age in US cohort. by Thierry Poynard (38084)

Effectiveness of interventions to decrease hesitancy. by Maximilian Nicolaus Burger (12969212)

Cadmium concentrations in Canadian durum exports decreased with the adoption of low accumulating cultivars by Sheryl A. Tittlemier (1560166)

MVK activates microglia and decreases phagocytosis. by Ren Y. Sato (16914027)

Initiation of corticosteroid therapy resulted in a decrease in IP-10 levels (ICU patients, n = 12). by Shaul Lev (779105)

Losartan increased ACE-2 expression, while SARS-CoV-2 spike protein decreased ACE-2 expression in hACE2 brains. by Mackenzi Meier (19251139)

“…<p>hACE2 KI mice were treated only with Losartan or intravenously injected with SARS-CoV-2 spike protein (SP, 4 μg/ animal) with or without Losartan (10 mg/kg body weight) for 2 weeks. …”

Metformin pre-administration decreases the oxidative stress, retains antioxidant effect and decreases apoptosis in colon and lung tissues in mice irradiated with GCRsim. by Silvia Siteni (10344070)

COVID-19 incidence increases over time with a decreased importance of genetic COVID-19 susceptibility. by C. A. Robert Warmerdam (12568808)

“…The shaded area represents the 95% confidence interval for the model fit. c) The contribution of COVID-19 susceptibility to the risk of having had COVID-19 slowly decreased over time. d) Regression coefficients of the COVID-19 susceptibility PGS and ever testing positive for SARS-CoV-2 by PCR test over time. …”

Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19. by Alejandro Piscoya (782326)

Subjects:

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Naringenin decreases mitochondrial function. by Lauren A. Eanes (20995499)

The catalase enzyme response of <i>A</i>. <i>albopictus</i> larvae decreased (1.5-fold) in response to <i>M</i>. <i>robertsii</i>-derived copper nanoparticles. by Perumal Vivekanandhan (4863484)

Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19. by Alejandro Piscoya (782326)

Subjects: